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Richard Gray1* , Ashish Badnapurkar2, Eman Hassanein2, Donna Thomas2, Laileah Barguir2, Charley Baker3,
Martin Jones4, Daniel Bressington5, Ellie Brown6 and Annie Topping2,7
Abstract
Background: Trial registration helps minimize publication and reporting bias. In leading medical journals, 96% of
published trials are registered. The aim of this study was to determine the proportion of randomized controlled
trials published in key nursing journals that met criteria for timely registration.
Methods: We reviewed all RCTs published in three (two general, one mental health) nursing journals between
August 2011 and September 2016. We classified the included trials as: 1. Not registered, 2. Registered but not
reported in manuscript, 3. Registered retrospectively, 4. Registered prospectively (before the recruitment of the first
subject into the trial). 5. Timely registration (as 4 but the trial identification number is reported in abstract).
Results: We identified 135 trials published in the three included journals. The majority (n = 78, 58%) were not
registered. Thirty-three (24%) were retrospectively registered. Of the 24 (18%) trials that were prospectively
registered, 11 (8%) met the criteria for timely registration.
Conclusions: There is an unacceptable difference in rates of trial registration between leading medical and nursing
journals. Concerted effort is required by nurse researchers, reviewers and journal editors to ensure that all trials are
registered in a timely way.
Background
Estimates indicate that up to 50% of clinical trials are
never published, profoundly distorting the evidence base
for clinical decision-making [1]. Researchers (and journal
editors), while highly motivated to publish findings from
trials reporting the effectiveness of a new drug or inter-
vention, tend to be rather less enthusiastic about
publishing trials that report negative or inconclusive
findings. Registration of trials before the first patient is
enrolled goes some way to ensuring that every study is
part of the public record and that anyone who is inter-
ested can identify whether the data analysis occurred
posthoc or outcome measures were amended part way
through. In 2004, the International Committee of
Medical Journal Editors (ICMJE) issued a statement that
from July 2005 all clinical trials published in their jour-
nals required registration in a public trial registry [2].
Additionally, the ICMJE issued a policy for Uniform
Requirements for Manuscripts (URM) that states that
the trial registry identifier must be included at the end
of the abstract (http://www.icmje.org/recommendations/
browse/publishing-and-editorial-issues/clinical-trial-
registration.html).
Authors of a study of 698 trials published in the five
ICMJE founding journals (that include the British
Medical Journal and the Lancet) reported that 96% of in-
cluded studies listed a trial identification number [3].
However, only 60% of trials were prospectively regis-
tered. These observations suggest that even among lead-
ing and well-respected journals there is work to do to
ensure timely registration. A study by Harriman and
Patel [4] examined rates of prospective and retrospective
registration in trials published in the BMC (BioMed
Central) series of journals in 2013. They reported that
97% of the 108 published trials were registered. This was
completed prospectively in only around a third of cases
(n = 33, 31%). Scott et al. [5] examined trial registration
in five leading psychiatry journals. Of 181 included trials
the authors reported that only 60 (33%) were prospect-
ively registered.* Correspondence: R.Gray@latrobe.edu.au1School of Nursing and Midwifery, La Trobe University, Melbourne, Australia
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Although many nursing journals encourage trial regis-
tration, editors, researchers and authors have not spoken
with the same clarity and consistency as their medical
colleagues, possibly explaining why seemingly few trials
published in nursing journals are registered. For ex-
ample, Jull and Aye [6] reported that of the 83 trials
published in the top 15 nursing journals in 2012, only 18
(22%) were registered. The authors report few specific
details about registration (for example, the length of
registration delay) [6].
In a keynote presentation at the INANE (International
Academy of Nursing Editors) conference in London in
the summer of 2016 Dr Ben Goldacre—one of the
leaders of the alltrials campaign (http://www.alltrials.-
net)—challenged the assembled audience of nursing
journal editors to ensure that trials published in the
journals they edit were registered. Inspired by this chal-
lenge, we published an editorial [7] in September 2016
where we reported a simple count of the proportion of
registered trials published in the Journal of Advanced
Nursing. We found that the authors of two-thirds of
published trials did not to report a registration number.
Reflecting on this observation, we felt there was a need
to develop this work further. We reviewed the literature
and identified no studies that have examined trial regis-
tration practices in key nursing journals. Therefore, we
aimed to conduct a study to examine the proportion of
RCTs published in three of the key nursing journals,
covering both general and mental health nursing that
met criteria for timely registration.
Methods
We decided not to focus on the three top journals listed
in the Journal Citation Report (JCR) under the field of
nursing (International Journal of Nursing Studies IF (im-
pact factor) = 3.561, Oncology Nursing Forum IF = 2.708,
European Journal of Cardiovascular Nursing IF = 2.491)
with the highest impact factors. This was because in
nursing, unlike in medicine, many of the leading journals
have a specialist focus (e.g., oncology, cardiovascular dis-
ease). We therefore decided to select what we judged
the key general and mental health journals in nursing
based on a combination of bibliometric indicators.
The included journals were the Journal of Advanced
Nursing (JAN), the International Journal of Nursing
Studies (IJNS) and the Journal of Psychiatric and Mental
Health Nursing (JPM). Journal Citation Report (total an-
nual citations and IF (ranked for the field, nursing
science)), Scopus CiteScore, and GoogleScholar h-5
index for included journals was:
 JAN (JCR total citations = 12,952 (rank 1/114) and
Impact Factor = 1.917 (ranking 9/114), Scopus
CiteScore = 2.29 (rank 5/91 for nursing),
GoogleScholar h5-index = 51 (ranked second for
nursing).
 IJNS (JCR total citations = 5,898 (ranking 3/114) and
Impact Factor = 3.561 (ranking 1/114), Scopus
CiteScore = 3.49 (rank 2/91 for nursing),
GoogleScholar h5-index = 53 (ranked first for
nursing).
 JPM (JCR total citation = 1,956 (rank 14/114) and
Impact Factor = 1.055 (ranking 56/114 for nursing
science), Scopus CiteScore = 1.26 (rank 8/38 for
psychiatric mental health), GoogleScholar h5-index =
27 (ranked 21st for nursing).
JAN author guidelines state that trials “should be regis-
tered publicly”; the IJNS “encourages” trial registration.
The JPM requires that authors submit a CONSORT
(Consolidated Standards for Reporting Randomized
Controlled Trials) checklist, where item 1b states the
registration number should be included [8].
We extracted all randomized clinical trials published
in included journals between the 1 September 2011 and
31 August 2016. For this study, we used the WHO [9]
definition of a clinical trial:
“A clinical trial is any research study that
prospectively assigns human participants or groups of
humans to one or more health-related interventions
to evaluate the effects on health outcomes.”
We excluded trials where participants were not ran-
domized (e.g., quasi-experimental studies). We did this
as there has been some debate among nursing editors
about the need for non-randomized studies to be regis-
tered [10]. Two researchers independently read the title
and abstract of every paper published in included jour-
nals looking for the phrases “randomized controlled,”
“pilot”, “feasibility”, “stepped wedge”, or “clinical trial.” A
five-year window was selected so that we could explore
trends in rates of registration. Full texts of manuscripts
were then retrieved and checked to ensure that the trial
reported met inclusion criteria. We excluded studies that
were not randomized, recruited subjects before 1 July
2005, or reported secondary analysis from a previously
published trial. From included studies, researchers ex-
tracted the following information:
 Name of publishing journal
 The trial registration number
 Trial registration number in the manuscript abstract
 If no trial registration number was reported (in
either the abstract or the body of the text), we
manually checked CTG, ISRCTN and the trial
registry for the country of the corresponding author
using keywords from the trial. Additionally, we also
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contacted the corresponding author by email to
check if the trial was registered. We did this to
assess if the trial had been registered but not
reported.
 Design (e.g., RCT, cluster RCT, stepped wedged,
pilot, feasibility)
 The country of affiliation given of the corresponding
author
 Presence of a conflict of interest statement
The trial registration number was used to extract the
following information from the relevant registry:
 The name of the registry
 The date the trial was registered
 The date the first subject was enrolled in the study
Four researchers (a combination of AB, EH, DT, and
LB) completed data extraction independently using a
form we devised for the study. Two team members
reviewed each paper. Coding discrepancies were dis-
cussed with a senior researcher (RG) who arbitrated a
final decision. We uploaded extracted data into SPSS
that was used to classify, describe, and analyze the data.
We classified included studies into five groups:
1. Not registered: the trial authors provided no
information about trial registration in the published
manuscript.
2. Registered but not reported: the trial was registered
but the registration number was not reported by the
authors anywhere in the manuscript.
3. Retrospectively registered: the time of trial
registration was after the date of first patient
enrollment into the trial.
4. Prospectively registered: the time of trial registration
preceded the date the first patient was enrolled into
the study.
5. Timely registration: as 4, but the papers abstract
contains the trial registration number (a ICMJE
URM requirement).
As in the Harriman and Patel [4] study, we also calcu-
lated the length of registration delay. We defined this as
the number of days between the date of first patient en-
rolment and the date of trial registration. We reported
the median number of days and IQR (interquartile
range) of delay for each journal.
We defined the date of trial registration as the date
the registration number was issued. If this date was not
stated, then we used the date of application to the regis-
try. There are some inconsistencies across registries
about how study start dates are recorded. Where pos-
sible, we intended to extract the actual date the first
patient was recruited. We were aware this would not al-
ways be possible. In instances where only the study start
date or anticipated start date were given, this was used
as a proxy for the date of first patient enrollment. If the
month/year but not the day of recruitment was recorded
in the database, then we assumed enrollment began on
the first of the month.
Results
Figure 1 shows the flow of papers through this study.
We identified 135 RCTs that met inclusion criteria
(Table 1). These represented 5% (n = 135/2852) of the
papers published in the three journals over the study
period (JAN n = 42/1350, 3%; IJNS n = 80/940, 9%; JPM
n = 13/562, 2%). Most of the studies were described as
RCTs; there were a small number of cluster (n = 11),
pilot (n = 5), feasibility (n = 2) and stepped wedge (n = 1)
trials. The majority (83/135, 62%) of trials were not reg-
istered. From checking trial registries and contacting au-
thors of unregistered studies directly we identified three
studies (3/78, 4%) that had been registered but registra-
tion was not reported in the manuscript. Ten percent of
trials were prospectively registered (n = 13/135) and
eight percent were prospectively registered with the trial
identification number in the abstract (timely registra-
tion) (n = 11/135).
Around a quarter of trials (n = 33/135, 24%) were reg-
istered retrospectively, the length of delay was between
39 and 2,463 days and the median was 675 (IQR 563–
1099) days (JAN median 1043, IQR 654–1074; IJNS me-
dian 778, IQR 241–1410). We were not able to calculate
the median or IQR for JPM as so few studies were
registered.
The most commonly used trial registry was CTG
(clinicaltrials.gov) (n = 31/57, 54%). Trial (corresponding)
authors came from 30 different countries, over half (n =
75/135, 56%) were from Asia. We observed that corre-
sponding authors from Asia were less likely to have
registered their trial compared with those from the rest
of the world. A post hoc analysis suggested this associ-
ation was statistically significant (OR = .30, 95% CI .15,
.61, p = 001).
The majority of study authors provided a conflicts of
interest statement (n = 125/135, 93%), typically authors
reported no competing interests. Table 2 shows the pro-
portion of studies registered in each of the 5 years. Over
the study period, we did not observe an obvious increase
in the number of trials published. There was also no ap-
parent trend suggesting an increase in the proportion of
trials registered.
Discussion
The aim of this study was to determine the proportion
of RCTs published in key nursing journals that met
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criteria for timely registration. As might be expected from
a maturing academic discipline that includes a broad re-
search constituency, RCTs made up only a modest pro-
portion of the manuscripts published. Nevertheless, few
included trials were registered. Our observation is slightly
more positive but broadly consistent with Jull and Aye [6]
who reported that 22% of trials published in 15 nursing
journals in 2012 were registered. This may suggest that
registration rates in the key journals we included are
higher than in nursing journals more generally.
Rates of registration in this study differed markedly to
those in trials published in medical journals. For ex-
ample, Harriman and Patel [4] and Huser and Cimino
[3], respectively, reported that only 3% of trials in BMC
journals and a similar proportion in ICMJE founding
journals were not registered. Lower rates of trial regis-
tration have been reported in specific areas of medicine;
for example, in a study of ten high impact surgical jour-
nals, 35% of trials were not registered [11]. There was a
marked difference in the rates of prospective registration
between JPM and the top psychiatry journals (0 vs. 33%)
[5], though there are comparatively very few trials pub-
lished in mental health nursing journals.
Possible explanations as to why registration rates were
low might include administrative delay in registration,
author awareness, and ambiguous journal author guide-
lines. There were no studies where registration occurred
within one month of the trial starting, suggesting that it
was not administrative issues that explained low registra-
tion rates. Instead, our findings may highlight a potential
lack of awareness of the importance of prospective regis-
tration, reflecting that this is an emerging topic for dis-
cussion in nursing research. This seems to be
particurarly profound among nurse investigators work-
ing in Asia. A study by Reveiz et al. [12] has reported
low levels of support among trialists for registration. We
were unable to identify any published studies that have
examined the views of nurse researchers about the im-
portance of trial registration; exploring their attitudes in
more detail would be illuminating for further research.
The ICMJE statement explicitly requires trial registration.
Two included journals broadly endorse registration (JAN
and IJNS). JPM requires authors submit a CONSORTcheck-
list, effectively ensuring that registration is required. There
remains a need to develop a greater awareness among nurse
authors, reviewers, and editors of the importance of trial
registration. In our view, all nursing journal editors need to
be explicit about the need for authors to register trials.
The authors of three trials had registered their study
but not reported that they had done so in the published
Fig. 1 PRISMA 2009 flow diagram
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manuscript. We note that for all three manuscripts
registration was retrospective. It is concerning that a
small number of authors had gone to the effort of regis-
tering their study but not felt that it is sufficiently im-
portant to report that they have done this.
The ethics of retrospective registration
In this study, if trials were registered, this was most likely
done retrospectively. Boughton [13] has discussed the
ethical dilemma of accepting retrospectively registered
trials for publication. On the one hand, considering a
retrospectively registered paper for publication under-
mines the aim of trial registration and some authors have
argued that the value of retrospective registration in
countering publication or selective reporting bias is negli-
gible [14, 15]. On the other hand, there is an ethical
responsibility to publish research, given the investment
subjects have made in volunteering to participate.
The Asia powerhouse
It is interesting to observe that the corresponding author
for the majority of included trials was from Asia. By con-
trast, most trials published in BMC journals were from
Europe. Our observations seem to suggest that Asia is a
powerhouse in nursing trials research, at least regarding




reported (n = 3)
Retrospectively
registered (n = 30)
Prospectively
registered (n = 13)
Prospectively registered
(ID in abstract) (n = 11)
Total
Journal
IJNS 40 (50%) 3 (4%) 20 (25%) 10 (12%) 7 (9%) 80
JAN 28 (67%) - 7 (17%) 3 (7%) 4 (10%) 42
JPM 10 (77%) - 3 (23%) - - 13
Trial registry
Clinicaltrial.gova - 2 (6%) 16 (52%) 5 (16%) 8 (26%) 31
ISRCTNb - - 6 (60%) 3 (30%) 1 (10%) 10
ANZCTRc - 1 (11%) 6 (67%) - 2 (22%) 9
HKRCTNd - - - 2 (100%) - 2
Iranian trail registrye - - 1 (100%) - - 1
Chinese trial registryf - - 1 (100%) - - 1
NTRg - - 0 (0%) 3 (100%) - 3
Design
RCT 75 (64%) 2 (2%) 24 (20%) 10 (8%) 7 (6%) 118
Cluster RCT 1 (9%) 1 (9%) 3 (27%) 3 (27%) 3 (27%) 11
Stepped wedge 1 (100%) - - - - 1
Pilot 3 (60%) - 2 (40%) - - 5
Feasibility study - - 1 (50%) - 1 (50%) 2
Continent of corresponding author affiliation
Asia 53 (71%) 2 (3%) 17 (23%) 2 (3%) 1 (1%) 75
Australia and NZ 3 (38%) 1 (13%) 3 (38%) - 1 (13%) 8
Europe 17 (40%) - 5 (16%) 11 (27%) 7 (17%) 40
North and South America 7 (54%) - 5 (36%) - 2 (14%) 14
Conflicts of interests
Declared 71 (57%) 3 (2%) 28 (23%) 13 (10%) 10 (8%) 125
Not declared 9 (75%) - 2 (17%) - 1 (8%) 12
aClinicaltrials.gov bISRCTN.org cAustralian New Zealand Clinical Trial Registry dHong Kong (not a WHO primary registry as of the 30th November 2016)
eIranian Clinical Trials Registry fChinese Clinical Trial Registry gThe Netherland National Trial Registry
Table 2 Number of RCTs registered over the 5-year study period
Year Date Total number of
included trials
Number of trials not
registered (n, %)
1 1 September 2011 to 31
August 2012
32 22 (69%)
2 1 September 2012 to 31
August 2013
22 11 (50%)
3 1 September 2013 to 31
August 2014
28 17 (61%)
4 1 September 2014 to 31
August 2015
34 17 (50%)
5 1 September 2015 to 31
August 2016
19 11 (58%)
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work published in some of the profession’s key journals.
That rates of registration are seemingly lower among
this group of authors is of concern and indicates that
work may be required to increase awareness in a global
sense, given the different compliance patterns identified.
Limitations
In this study, our denominator was the total number of
published randomized controlled trials. We excluded non-
RCTs (e.g., controlled clinical trials) as there continues to
be some debate about whether registration is required
[10]. Arguably, we could have been more inclusive in the
types of trials we included. The consequence may be that
we have overestimated rates of trial registration.
We extracted the study start date from the trial registry
record. Some manuscripts may also have included details
of trial start dates. We did not check if registry/manu-
script dates matched. It is possible that some start dates
recorded in trial registries were inaccurate, i.e., that the
trial started later than reported. This may mean that we
had incorrectly classified some trials as retrospectively
registered when in fact they were prospectively registered.
However, we assert that it is the responsibility of the re-
search team to ensure that their trial registry entry is up
to date and correct. We would recommend that in future
studies of this type, both registry and manuscript recorded
start dates are extracted, checked, and any inconsistencies
resolved with the trial corresponding author.
In this study, we did not compare registered to pub-
lished outcomes or outcome classification (e.g., primary,
secondary). Previous authors have observed that regis-
tered and published outcomes are often different [14].
This is a major limitation and we would recommend
that future research should address this deficit.
We have incorporated a list of included papers as a sup-
plementary document (Additional file 1). The classifica-
tion we assigned to each study is not included. This may
be considered a limitation of our study. However, we were
concerned that publishing our classifications may lead to
a perception of “naming and shaming” those who had not
registered their trials. We feel that such a response would
be counter to our intention in conducting this study that
was primarily to raise awareness of the need for timely
prospective registration of trials by nursing researchers
and authors. It may be that authors of future studies could
consider including these data in their reporting.
Our current study is, of course, a snapshot of three
journals, and we cannot be confident that our observa-
tions are generalizable to all nursing journals.
Conclusions
Our study draws attention to important shortcomings in
the reporting of clinical trials in nursing journals. There
are over a hundred journals (n = 114) listed in the JCR
under the field of nursing (science). In this study, we
focused on just three, which are, arguably, key general/
mental health journals in the field. It is important that all
nursing journals have a clear and explicit policy requiring
registration of trial they publish. However, we recognize
that enforcing these policies is challenging. Editors clearly
have an important role to play, but ultimately there is no
real incentive for them to mandate registration. Perhaps,
as in medicine, editors of leading journals need to work
collaboratively and to ensure that they lead by example.
Additional file
Additional file 1: Included studies. (DOCX 31 kb)
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